Product Overview

(4R,12aS)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid is a structurally complex pharmaceutical intermediate widely used in the synthesis of nucleoside analogs and innovative drugs such as antiviral and antitumor drugs. This compound exhibits high stereoselectivity, making it suitable for drug molecule skeleton construction and functional group introduction. It can meet the needs of small-scale, pilot-scale, and large-scale production in the R&D stage, and is a key starting material in the development of novel drugs.

Applications

• Nucleoside analogue synthesis
• Antiviral drug intermediate development
• Antitumor drug process optimization
• Innovative drug molecule skeleton construction
• Customized pharmaceutical synthesis projects

Quality & Supply Capability

English Name: (4R,12aS)-7-Methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxylic acid Properties: This product is a white to off-white solid with high purity, stable structure, and well-defined stereochemical characteristics. It is suitable for the construction of complex drug molecules and possesses good reactivity and compatibility. Storage Recommendations: Store in a sealed, light-proof, and dry place, subject to the specific requirements of the COA/MSDS. Supply Capabilities: Samples, gram-level, kilogram-level, commercial-scale batches. Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging. Documentation Support: COA, MSDS, HPLC, NMR, etc. We provide a full-process service from laboratory sample supply to small-scale preparation, pilot-scale amplification, and customized mass production. We can flexibly adjust purity standards, impurity control schemes, packaging specifications, and delivery cycles according to customer needs, and provide complete quality documentation support. Simultaneously, we provide technical support from laboratory research and development to industrial scale-up, helping customers complete process development, route optimization, and project transformation, ensuring efficient and compliant drug development.

Why Choose Bioncan

Focused on pharmaceutical intermediates, with extensive experience in nucleoside compound synthesis. Full-scale supply capability, covering sample, gram, kilogram, and commercial batch sizes. Provides complete quality control documentation, including COA, MSDS, HPLC, NMR, etc. Supports customized needs, adjusting purity, impurity control, and packaging specifications according to customer requirements. Provides process optimization and scale-up technical support to help customers achieve efficient commercialization.

Online Consulting

For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 1335210-34-8, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.